The last week of SPACs was packed with market activity including deals, IPOs, and Lawsuits.
The SPAC bubble burst has led to the market being flooded with penny stocks.
Also, a serial sponsor upsizes its IPO for its next SPAC, a SPAC is taking a drug development firm public, and a medical testing firm comes under scrutiny due to mounting losses and lawsuits from customers.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.